These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The value of liver function tests in hepatocellular carcinoma. Lopez JB, Balasegaram M, Thambyrajah V, Timor J. Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229 [Abstract] [Full Text] [Related]
14. Association between elevated serum hepatic enzyme activity and total body fat in obese humans. Choi JW. Ann Clin Lab Sci; 2003 Dec; 33(3):257-64. PubMed ID: 12956439 [Abstract] [Full Text] [Related]
17. [Measurement of serum immunoreactive beta-glucuronidase: a possible serological marker for histological hepatic cell necrosis and to predict the histological progression of hepatitis]. Ohta H. Hokkaido Igaku Zasshi; 1991 Jul; 66(4):545-57. PubMed ID: 1655603 [Abstract] [Full Text] [Related]
18. Serum proteolytic activities and antiproteases in human colorectal carcinoma. Amiguet JA, Jiménez J, Monreal JI, Hernández MJ, López-Vivanco G, Vidán JR, Conchillo F, Liso P. J Physiol Biochem; 1998 Mar; 54(1):9-13. PubMed ID: 9732103 [Abstract] [Full Text] [Related]
19. Changes in serum cathepsin B-like activity in patients with colorectal cancer. Dufek V, Jirásek V, Král V, Matous B, Drazná E. Neoplasma; 1985 Mar; 32(1):51-4. PubMed ID: 3982561 [Abstract] [Full Text] [Related]